Trxade Group to Postpone Virtual Roadshow Presentation

Rhea-AI Summary

Trxade Group, Inc. (MEDS) has announced the postponement of its virtual roadshow, originally set for February 3, 2021. The new date will be communicated through a future press release, which will include webcast links and dial-in information. CEO Suren Ajjarapu expressed gratitude to shareholders for their patience while emphasizing the company's focus on achieving short-term business objectives. Trxade Group operates as a comprehensive drug procurement and healthcare platform across the U.S. with a mission to enhance price transparency in the pharmaceutical market.

Positive

• The company operates a comprehensive healthcare platform enhancing price transparency.
• Approximately 12,000 registered users on its B2B trading platform.

Negative

• Postponement of the virtual roadshow may signal uncertainty in corporate updates.

TAMPA, FL, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (MEDS) an integrated drug procurement, delivery and healthcare platform, today announced that it will postpone its virtual roadshow, previously scheduled for Wednesday, February 3, 2021 at 11:00 a.m. Eastern Time, to a later date that will be announced via press release.

“The virtual roadshow will be postponed to a later date, which will be announced via press release accompanied by a webcast link and dial-in numbers once finalized,” said Suren Ajjarapu, Chief Executive Officer of Trxade Group. “I would like to thank our shareholders for their patience as we continue to execute upon our near-term business objectives. I look forward to presenting an overview of the business model, short-term growth initiatives and a corporate update to both new and prospective investors.”

About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ:MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; (1) the Trxade B2B trading platform with approximately 12,000 registered users, (2) Integra Pharma Solutions, Trxade Group's virtual wholesale division, and (3) the Bonum Health platform offering affordable telehealth services. For additional information, please visit us at www.trxade.com or at www.bonumhealth.com.

Investor Relations:
Lucas Zimmerman
Senior Vice President
MZ Group - MZ North America
(949) 259-4987
MEDS@mzgroup.us
www.mzgroup.us

FAQ

Why did Trxade Group postpone its virtual roadshow?

Trxade Group postponed its virtual roadshow to a later date to better align with its business objectives, with a new date to be announced via press release.

What is the scheduled date for the Trxade Group virtual roadshow?

The virtual roadshow was initially scheduled for February 3, 2021, but has been postponed to a later date yet to be determined.

What does Trxade Group do?

Trxade Group is an integrated drug procurement and healthcare platform that aims to improve price transparency and accessibility of pharmaceuticals across the U.S.

What is the stock symbol for Trxade Group?

The stock symbol for Trxade Group is MEDS, which is traded on NASDAQ.